Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
02/26/2013 | CA2477312C Use of soluble fgl2 as an immunosuppressant |
02/26/2013 | CA2440775C The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
02/26/2013 | CA2430115C Recombinant rsv virus expression systems and vaccines |
02/26/2013 | CA2389644C A novel polypeptide hormone phosphatonin |
02/26/2013 | CA2380302C Production of proteins by autoproteolytic cleavage |
02/26/2013 | CA2369844C Nucleic acid sequences to proteins involved in tocopherol synthesis |
02/26/2013 | CA2358570C Protonated/acidified nucleic acids and methods of use |
02/26/2013 | CA2350335C Host cells expressing recombinant human erythropoietin |
02/26/2013 | CA2342115C Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use |
02/26/2013 | CA2327586C Fap.alpha.-specific antibody with improved producibility |
02/26/2013 | CA2324648C Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
02/26/2013 | CA2324381C An integrin heterodimer and a subunit thereof |
02/21/2013 | WO2013026054A2 Production of infectious rna viruses in yeast |
02/21/2013 | WO2013025972A1 Yeast-muc1 immunotherapeutic compositions and uses thereof |
02/21/2013 | WO2013025963A2 Conversion of somatic cells into functional spinal motor neurons, and methods and uses thereof |
02/21/2013 | WO2013025945A2 Variant sucrose transporter polypeptides that enable faster sucrose utilization in bacteria |
02/21/2013 | WO2013025936A1 Detection and treatment of metastatic disease |
02/21/2013 | WO2013025930A1 Aptamer modulators of estrogen receptors |
02/21/2013 | WO2013025846A2 Transferrin-tumstatin fusion protein and methods for producing and using the same |
02/21/2013 | WO2013025773A2 Molecular markers associated with soybean root-knot nematode tolerance and methods of their use |
02/21/2013 | WO2013025670A1 Methods and compositions for introduction of exogenous dsrna into plant cells |
02/21/2013 | WO2013025485A1 Transcription terminators |
02/21/2013 | WO2013025479A1 Jaml specific binding agents, antibodies, and uses related thereto |
02/21/2013 | WO2013025400A1 Maize event hcem485, compositions and methods for detecting and use thereof |
02/21/2013 | WO2013025322A2 Marker-based prognostic risk score in liver cancer |
02/21/2013 | WO2013025286A1 Recombinant bacteria having improved sucrose utilization |
02/21/2013 | WO2013024947A1 Microorganism having enhanced l-valine productivity and method for producing l-valine using the same |
02/21/2013 | WO2013024909A1 Novel paenibacillus sp. hpl-001 strain for producing highly active xylanase having heat resistance and a wide ph range, novel xylanase enzyme isolated therefrom, and method for mass-producing same using a transformant thereof |
02/21/2013 | WO2013024867A1 Antibody and use thereof |
02/21/2013 | WO2013024843A1 Ceramide derivative and golgi apparatus-labeling fluorescent probe using same |
02/21/2013 | WO2013024821A1 Suspension for parallel reaction, parallel reaction method, and screening method |
02/21/2013 | WO2013024763A1 Production method for nucleic acid aptamer |
02/21/2013 | WO2013024737A1 Method and kit for determining mushroom cultivation period |
02/21/2013 | WO2013024710A1 Medicinal agent for evading immune response |
02/21/2013 | WO2013024694A1 Solid-phase carrier for aminated oligonucleotide |
02/21/2013 | WO2013024582A1 Mphosph1 peptides and vaccines including the same |
02/21/2013 | WO2013024527A1 Method for producing alkane and recombinant microorganism having alkane-synthesizing ability |
02/21/2013 | WO2013024469A1 Methods and compositions for diagnosis of alzheimer's desease |
02/21/2013 | WO2013024440A1 Nucleic acid agents for overexpressing or downregulating rna interference targets and uses of same in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant |
02/21/2013 | WO2013024438A1 ISOLATED POLYNUCLEOTIDES EXPRESSING OR MODULATING dsRNAs, TRANSGENIC PLANTS COMPRISING SAME AND USES THEREOF IN IMPROVING NITROGEN USE EFFICIENCY, ABIOTIC STRESS TOLERANCE, BIOMASS, VIGOR OR YIELD OF A PLANT |
02/21/2013 | WO2013024121A2 Increase of sucrose transporter activity in the seeds of plants |
02/21/2013 | WO2013024074A1 Plasminogen and plasmin variants |
02/21/2013 | WO2013024072A1 Method for isolating nucleic acids |
02/21/2013 | WO2013024066A1 Bacterially formed microcin s, a new antimicrobial peptide, effective against pathogenic microorganisms, e.g. enterohemorrhagic escherichia coli (ehec) |
02/21/2013 | WO2013024064A1 Composition and methods for rt-pcr comprising an anionic polymer |
02/21/2013 | WO2013023992A1 Guard cell-specific expression of transgenes in cotton |
02/21/2013 | WO2013023982A1 Novel compounds for the treatment of inflammatory bowel disease |
02/21/2013 | WO2013023623A1 Isolation, cloning and application of pms3, a gene for photoperiod-sensitive genic male-sterility in rice |
02/21/2013 | WO2013023557A1 Humanized monoclone antibody of macrophage inhibition factor 1 and use thereof |
02/21/2013 | WO2013023361A1 Uses of human zfx gene and related drugs thereof |
02/21/2013 | WO2013023251A1 Soluble polypeptides |
02/21/2013 | WO2013023243A1 Methods of controlling fructan synthesis in plants |
02/21/2013 | WO2013006861A9 Sorghum grain shattering gene and uses thereof in altering seed dispersal |
02/21/2013 | WO2012177089A3 Interspecific and intraspecific chlorella strain microsatellite molecular marker |
02/21/2013 | WO2012176115A3 Plants having enhanced yield-related traits and a method for making the same |
02/21/2013 | WO2012176016A8 Cassettes and methods for transforming and selecting yeast transformants by homologous recombination |
02/21/2013 | WO2012174224A3 Methods for administering nucleic acid-based therapeutics |
02/21/2013 | WO2012162394A3 Compositions and methods for treating renal disease |
02/21/2013 | WO2012160528A3 Development of phytophthora resistant potato with increased yield |
02/21/2013 | WO2012156817A3 Method for treating non-small cell lung cancer |
02/21/2013 | WO2012150818A9 Method for predicting a risk of chronic myeloid leukemia, and diagnosis kit using same |
02/21/2013 | WO2012124943A9 Recombinant microorganism having ability to produce [lactate-co-glycolate] copolymer from glucose, and method for preparing [lactate-co-glycolate] copolymer using same |
02/21/2013 | WO2012124941A9 Recombinant microorganism having ability to produce polyhydroxyalkanoate containing 2-hydroxybutyrate as monomer, and method for preparing polyhydroxyalkanoate containing 2-hydroxybutyrate as monomer using same |
02/21/2013 | WO2012108630A9 Sbta gene derived from synechocystis sp. pcc6803 and use thereof |
02/21/2013 | WO2011116954A8 Prophylaxis of colorectal and gastrointestinal cancer |
02/21/2013 | US20130047300 Grain Filling of a Plant Through the Modulation of NADH-Glutamate Synthase |
02/21/2013 | US20130047299 Defensin-Encoding Nucleic Acid Molecules Derived From Nicotiana Alata, Uses Therefor And Transgenic Plants Comprising Same |
02/21/2013 | US20130047297 Polynucleotide molecules for gene regulation in plants |
02/21/2013 | US20130047296 Plants and seeds of sorghum variety gsv206860 |
02/21/2013 | US20130047295 Soybean cultivar 08093572 |
02/21/2013 | US20130047294 Soybean cultivar 03284882 |
02/21/2013 | US20130046081 Fully human monoclonal antibody to vegf, preparation method and use thereof |
02/21/2013 | US20130046079 Mouse lambda light chain locus |
02/21/2013 | US20130046007 Selective reduction of allelic variants |
02/21/2013 | US20130045917 Method of selecting polypeptide sequence, and metal oxide or silicon-containing compound binding peptide and use thereof |
02/21/2013 | US20130045539 Meganuclease recombination system |
02/21/2013 | US20130045538 Modified u7 snrnas for treatment of neuromuscular diseases |
02/21/2013 | US20130045537 Methods and compositions relating to multiciliate cell differentiation |
02/21/2013 | US20130045533 Modular transport platform for targeted delivery of therapeutic agents |
02/21/2013 | US20130045524 Subtilases |
02/21/2013 | US20130045520 Double-stranded oligonucleotides |
02/21/2013 | US20130045515 Heterogeneous e. coli for improving fatty acid content using fatty acid biosynthesis and preparation method thereof |
02/21/2013 | US20130045510 Novel Beta-Glucosidase and Uses thereof |
02/21/2013 | US20130045508 Cell extract promoted cloning |
02/21/2013 | US20130045506 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
02/21/2013 | US20130045505 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
02/21/2013 | US20130045479 Methods for evaluating the stage of ovarian cancer or the survival rate of an ovarian cancer patient |
02/21/2013 | US20130045476 Method for combined monitoring of detection of at least two molecular targets and to a kit therefor |
02/21/2013 | US20130045325 Methods of increasing protein, oil, and/or amino acid content in a plant |
02/21/2013 | US20130045324 Methods of increasing protein, oil, and/or amino acid content in a plant |
02/21/2013 | US20130045323 Methods of increasing protein, oil, and/or amino acid content in a plant |
02/21/2013 | US20130045244 Modified adam disintegrin domain polypeptides and uses thereof |
02/21/2013 | US20130045234 Neutralizing factors as vaccine adjuvants |
02/21/2013 | US20130045233 Novel Allergen |
02/21/2013 | US20130045221 T-cell receptor capable of recognising an antigen from cytomegalovirus |
02/21/2013 | US20130045219 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
02/21/2013 | US20130045214 P53 modulator and cancer target |
02/21/2013 | US20130045207 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa |
02/21/2013 | US20130045206 Antibodies directed against the transferrin receptor and uses thereof for immunotherapy of iron-dependent tumours |
02/21/2013 | US20130045205 Methods and Compositions Related to Glycoprotein-Immunoglobulin Fusions |